357P Targeting dual metabolic pathway specifically killed malignant lymphoma cells
نویسندگان
چکیده
منابع مشابه
Targeting Wnt pathway in mantle cell lymphoma-initiating cells
BACKGROUND Mantle cell lymphoma (MCL) is an aggressive and incurable form of non-Hodgkin's lymphoma. Despite initial intense chemotherapy, up to 50% of cases of MCL relapse often in a chemoresistant form. We hypothesized that the recently identified MCL-initiating cells (MCL-ICs) are the main reason for relapse and chemoresistance of MCL. Cancer stem cell-related pathways such as Wnt could be r...
متن کاملPRIMARY MALIGNANT LYMPHOMA OF THE BREAST
A case of primary malignant non-Hodgkin's lymphoma of the breast is reported. This is the first well-documented case of breast lymphoma in our institution and also in Iran. The diagnosis of primary breast lymphoma requires the presence of lymphomatous infiltration in close ass, tissue in patients with neither previous lymphoma nor concurrent lymphoma in another site. There is no definite cl...
متن کاملTargeting constitutive NF-κB specifically in tumor cells
NF-κB transcription factors are the key regulators of innate and adaptive immune responses, inflammation, and cell survival [1]. Considerable evidences indicate that NF-κB plays important roles in carcinogenesis, cancer progression, metastasis and drug resistance, and therefore NF-κB has been regarded as one of the most important targets for cancer therapy [2]. However, the application of inhib...
متن کاملTargeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.
UNLABELLED MTOR complex-1(mTORC1) activation occurs frequently in cancers, yet clinical efficacy of rapalogs is limited because of the associated activation of upstream survival pathways. An alternative approach is to inhibit downstream of mTORC1; therefore, acquired resistance to fludarabine (Flu), a purine analogue and antimetabolite chemotherapy, active agent for chronic lymphocytic leukemia...
متن کاملTargeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
OBJECTIVE The present study sought to determine whether the Hedgehog (Hh) pathway is active and regulates the cell growth of cultured malignant pleural mesothelioma (MPM) cells and to evaluate the efficacy of pathway blockade using smoothened (SMO) antagonists (SMO inhibitor GDC-0449 or the antifungal drug itraconazole [ITRA]) or Gli inhibitors (GANT61 or the antileukemia drug arsenic trioxide ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2016
ISSN: 0923-7534
DOI: 10.1016/s0923-7534(21)00515-9